70
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Antinociceptive effects of topical mepivacaine in a rat model of HIV-associated peripheral neuropathic pain

&
Pages 361-371 | Published online: 06 Jun 2016

References

  • FreemanRBaronRBouhassiaraDCabreraJEmirBSensory profiles of patients with neuropathic pain based on neuropathic pain symptoms and signsPain201415536737624472518
  • PhillipsTJCCherryCLCoxSMarshallSJRiceASCPharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trialsPLoS ONE20105e1443321203440
  • Robinson-PappJMorgelloSVaidaFAssociation of self-reported painful symptoms with clinical and neurophysiological signs in HIV-associated sensory neuropathyPain201015173273620851521
  • RobertsonKKumwendaJSupparatpinyoKA multinational study of neurological performance in antiretroviral therapy-naive HIV-1-infected persons in diverse resource-constrained settingsJ Neurovirol20111743844721786076
  • SchützSGRobinson-PappJHIV-related neuropathy: current perspectivesHIV/AIDS (Auckl)20135243251
  • VermaSEstanislaoLSimpsonDHIV-associated neuropathic pain: epidemiology, pathophysiology and managementCNS Drugs20051932533415813646
  • KemperCAKentGBurtonSDeresinskiSCMexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trialJ Acquir Immune Defic Syndr Hum Retrovirol1998193673729833745
  • KieburtzKSimpsonDYiannoutsosCA randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol TeamNeurology199851168216889855523
  • ShlayJCChalonerKMaxMBAcupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized control trialJAMA1998280159015959820261
  • SimpsonDMDorfmanDOlneyRKPeptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trialNeurology199647125412598909439
  • AttalNCruccuGBaronREuropean Federation of Neurological SocietiesEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol2010171113e8820402746
  • DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain200713223725117920770
  • EstanislaoLCarterKMcArthurJOlneyRSimpson D; GroupL-HNA randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathyJ Acquir Immune Defic Syndr2004371584158615577414
  • BrockmannWGMepivacaine: a closer look at its properties and current utilityGen Dent201462707525369391
  • RadwanIASaitoSGotoFThe neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaineAnesth Analg20029431932411812691
  • LeeHIParkYSChoTGParkSWKwonJTKimYBTransient adverse neurologic effects of spinal pain blocksJ Korean Neurosurg Soc20125222823323115666
  • HerzbergUSagenJPeripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosisJ Neuroimmunol2001116293911311327
  • WallaceVCBlackbeardJPhebyTPharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathyPain2007133476317433546
  • ApostolskiSMcAlarneyTHaysAPLatovNComplement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1Immunol Invest19942347528144198
  • MilliganEDMehmertKKHindeJLThermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120Brain Res200086110511610751570
  • OhSBTranPBGillardSEHurleyRWHammondDLMillerRJChemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neuronsJ Neurosci2001215027503511438578
  • KeswaniSCPolleyMPardoCAGriffinJWMcArthurJCHokeASchwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neuronsAnn Neurol20035428729612953261
  • JonesGZhuYSilvaCPeripheral nerve-derived HIV-1 is predominately CCR5-dependent and causes neuronal degeneration and neuroinflammationVirology200533417819315780868
  • MelliGKeswaniSCFischerAChenWHokeASpatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathyBrain20061291330133816537566
  • BabulNHamaABaslerABaumJSagenJResponse to the local anesthetic TQ-1019 in the GP120 model of painful HIV neuropathy12th World Congress on PainAug, 17–24, 2012Glasgow, Scotland Abstract PW350
  • RusakovaLBabulNCastellanosDWeinrichJBaumDSagenJAntinociceptive response of the local anesthetic TQ-1019 in the radiant heat tail flick assay12th World Congress on PainAug, 17–24, 2012Glasgow, Scotland Abstract PW353
  • HargreavesKDubnerRBrownFFloresCJorisJA new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain19883277883340425
  • AnitescuMBenzonHTArgoffCEAdvances in topical analgesicsCurr Opin Anesthesiol201326555561
  • WiffenDSMooreRAQuinlanJTopical lidocaine for neuropathic pain in adultsCochrane Database Syst Rev20147CD01095825058164
  • KolesnikovYAChereshnevIPasternakGWAnalgesic synergy between topical lidocaine and topical opioidsJ Pharmacol Exp Ther200029554655111046087
  • GhoshRKGhoshSMChawlaSRecent advances in antiretroviral drugsExpert Opin Pharmacother201112314620698725
  • EllisRJToperoffWVaidaFSmoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trialNeuropsychopharmacology20093467268018688212
  • AbramsDIJayCAShadeSBCannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trialNeurology20076851552117296917
  • PaiceJAFerransCELashleyFRVizgirdaVPitrakDTopical capsaicin in the management of HIV-associated peripheral neuropathyJ Pain Symptom Manage200019455210687326
  • SimpsonDMBrownSTobiasJNGX-4010 C107 Study GroupControlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathyNeurology2008702305231318541884
  • SimpsonDMEstanislaoLBrownSHSampsonJAn open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathyJ Pain Symptom Manage20083529930617959343
  • SimpsonDMBrownSTobiasJKVanhoveGFNGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathyClin J Pain20143013414223446088
  • SimpsonDMMcArthurJCOlneyRLamotrigine HIV Neuropathy Study TeamLamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trialNeurology2003601508151412743240
  • SimpsonDMOlneyRMcArthurJCKhanAGodboldJEbel-FrommerKA placebo-controlled trial of lamotrigine for painful HIV-associated neuropathyNeurology2000542115211910851374
  • BaronRPeripheral neuropathic pain: from mechanisms to symptomsClin J Pain200016S12S2010870735
  • NasirinezhadFJergovaSPearsonJPSagenJAttenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat mode of HIV sensory neuropathyNeuropharmacology20159510010925486617
  • SorkinLSXiaoWHWagnerRMyersRRTumour necrosis factor-alpha indices ectopic activity in nociceptive primary afferent fibersNeuroscience1997812552629300418
  • FloresMPCastroAPNascimentoJSTopical analgesicsRev Bras Anestesiol20126224425422440379
  • KirillovaITeilbanAGorodetskayaNEffect of local and intravenous lidocaine on ongoing activity in injured afferent nerve fibersPain20111521562157121474243
  • DeversAGalerBSTopical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label studyClin J Pain20001620520811014393
  • MeierTWasnerGFaustMEfficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled studyPain20031615115814581122
  • MadsenCSJohnsenBJFulglsang-FrederiksenAJensenTSFinnerupNBDifferential effects of a 5% lidocaine medicated patch in peripheral nerve injuryMuscle Nerve20134826527123653369
  • PeppinJFAlbrechtPJArgoffCSkin matters: a review of topical treatments for chronic pain. Part two: treatments and applicationsPain Ther20154335025630651
  • ChoCWChoiJSShinSCEnhanced local anesthetic action of mepivacaine from the bioadhesive gelsPak J Pharm Sci201124879321190925
  • KangCShinSCDevelopment of prilocaine gels for enhanced local anesthetic actionArch Pharm Res2012351197120422864742